The global CAR T-cell therapy market is experiencing significant growth, driven by growing demand for cutting-edge cancer treatment options. This exponential expansion is fueled by elements such as the authorization of CAR T-cell therapies for multiple conditions, advancements in manufacturing technologies, and growing research and development prog